Video: Адренергические агонисты: агенты смешанного действия

СВЯЖИТЕСЬ С НАМИ

Войдите в систему

Mixed-acting adrenergic agonists act directly by stimulating adrenoceptors and indirectly by releasing stored catecholamines from the nerve terminals.

Unlike endogenous catecholamines, mixed-acting agonists lack a catechol moiety, making them poor substrates for metabolizing enzymes, increasing their duration of action.

Both ephedrine and pseudoephedrine exhibit excellent oral bioavailability and CNS penetration but are less potent than catecholamines.

Ephedrine—isolated from the Ephedra plant—has been used as an orally active sympathomimetic for treating asthma.

As ephedrine causes cardiac stimulation and vasoconstriction, it is used for treating anesthesia-induced hypotension. However, it is a less potent bronchodilator than isoprenaline or adrenaline.

Additionally, its central stimulatory effects are responsible for its abuse as a performance enhancer.

Pseudoephedrine—an ephedrine isomer with more indirect action—is orally effective and has fewer CNS effects. It is mainly used as a decongestant.

As it is commonly used as a precursor in illegal methamphetamine production, its sale is strictly regulated.

Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.

Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by prior treatment with catecholamine-depleting agents like guanethidine or reserpine.

Ephedrine, the first orally active sympathomimetic, is used for asthma and nasal congestion. However, its potential for secondary abuse and the availability of safer alternatives have limited its use. Pseudoephedrine is primarily used as a nasal decongestant but is strictly regulated due to its potential for the illicit synthesis of methamphetamine.

Теги

Adrenergic Agonists Mixed action Agents Ephedrine Pseudoephedrine Adrenoceptors Neurotransmitters Oral Bioavailability Lipophilicity Duration Of Action Sympathomimetic Asthma Treatment Nasal Congestion Secondary Abuse Nasal Decongestant Methamphetamine Synthesis

Из главы 6:

article

Now Playing

6.7 : Adrenergic Agonists: Mixed-Action Agents

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

558 Просмотры

article

6.1 : Адренергические нейроны: нейротрансмиссия

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

3.1K Просмотры

article

6.2 : Адренорецепторы (адренорецепторы): классификация

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

1.9K Просмотры

article

6.3 : Адренергические рецепторы: ɑ Подтип

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

1.3K Просмотры

article

6.4 : Адренергические рецепторы: подтип β

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

1.3K Просмотры

article

6.5 : Адренергические агонисты: агенты прямого действия

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

1.2K Просмотры

article

6.6 : Адренергические агонисты: агенты косвенного действия

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

1.3K Просмотры

article

6.8 : Адренергические агонисты: химия и взаимосвязь структуры и активности

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

2.4K Просмотры

article

6.9 : Адренергические агонисты: терапевтическая классификация

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

555 Просмотры

article

6.10 : Адренергические агонисты: терапевтическое применение

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

632 Просмотры

article

6.11 : Адренергические антагонисты: химия и классификация блокаторов ɑ-рецепторов

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

703 Просмотры

article

6.12 : Адреноблокаторы: фармакологическое действие блокаторов ɑ-рецепторов

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

457 Просмотры

article

6.13 : Адреноблокаторы: химия и классификация блокаторов β-рецепторов

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

423 Просмотры

article

6.14 : Адреноблокаторы: фармакологические действия блокаторов β-рецепторов

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

435 Просмотры

article

6.15 : Адренергические антагонисты: ɑ и блокаторы β-рецепторов

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

344 Просмотры

See More

Конфиденциальность

Условия эксплуатации

Политика

СВЯЖИТЕСЬ С НАМИ

РЕКОМЕНДОВАТЬ БИБЛИОТЕКЕ

НОВОСТИ JoVE

Исследования

Образование

АВТОРЫ

Библиотекарь

О JoVE

Авторские права © 2025 MyJoVE Corporation. Все права защищены